Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a novel orexin receptor 2 (OX2R) agonist, in ...

As the Canadian economy navigates a period of cooling labor markets and anticipated rate cuts by the Bank of Canada, investors are keeping a close watch on how these macroeconomic shifts might ...